Unity Biotechnology, Inc. filed an amended 8-K on July 21, 2025, to update their former address and reported that on July 22, 2025, they sold one share of Series A Preferred Stock to their President for $1.00 as part of a planned dissolution of the company agreed upon by the Board on June 27, 2025.